A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue
Status unconfirmed
Conditions studied: Breast Cancer Screening
In brief
Investigation of a tear-based, lab-developed biological test for breast cancer, as a supplemental tool to current screening recommendations for women with dense breast tissue will explore if a tear-based biological test can be used as a support tool in the breast cancer screening protocol for women with dense breast tissue. The test was designed and validated by Namida Lab, Inc., a high complexity Clinical Laboratory Improvement Amendments (CLIA) certified lab.
Key facts
- Study ID
- NCT05268224
- Run by
- Namida Lab
- People needed
- 1500
- Starts
- 2021-10-01
- Expected to finish
- 2024-10-01
- Last updated by the study team
- 2023-12-11
Who can join
Age: 18 and older, up to 100. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Categorized as having heterogeneously dense or extremely dense tissue 18 years of age or older Able to understand the informed consent process Willing to comply with all study procedures
You may not qualify if…
- Have an active eye infection Categorized as having fibro glandular densities or fatty breast tissue Currently diagnosed or are receiving treatment for breast cancer Under 18 years of age
Where it is running
- Namida Lab — Fayetteville, Arkansas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.